| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |